Daito ChemixDaito Chemix Corporation4366東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥4 is left as operating profit. Revenue changed +4.5% from the prior year, operating profit +2.8%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 9.8% | 0.75× | 7.4% | 1.62× | 11.9% |
| 2023 | 5.6% | 0.71× | 4.0% | 1.69× | 6.7% |
| 2024 | — | —× | -4.0% | —× | — |
| 2025 | 4.4% | 0.76× | 3.3% | 1.85× | 6.2% |
| 2026 | 4.1% | 0.73× | 3.0% | 1.90× | 5.6% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 16,134 | 16,377 | 15,811 | 18,644 | 19,476 |
| Cost of revenue | 13,205 | 13,942 | 13,911 | 16,571 | 17,258 |
| Gross profit | 2,929 | 2,434 | 1,900 | 2,073 | 2,218 |
| SG&A | 1,165 | 1,150 | 1,124 | 1,225 | 1,345 |
| Operating income | 1,763 | 1,283 | 776 | 848 | 872 |
| Pretax income | 1,751 | 1,291 | -678 | 853 | 1,013 |
| Income tax | 168 | 368 | 327 | 33 | 222 |
| Net income attributable to owners | 1,583 | 922 | -1,005 | 820 | 791 |
| Operating margin | 10.9% | 7.8% | 4.9% | 4.5% | 4.5% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥3.42B | ¥2.39B | ¥2.25B | ¥2.77B | ¥4.85B |
| Total assets | ¥21.5B | ¥24.7B | ¥25B | ¥24.3B | ¥28.8B |
| Net assets | ¥14.3B | ¥15.2B | ¥14.5B | ¥14.9B | ¥16.4B |
| Share capital | ¥2.9B | ¥2.9B | ¥2.9B | ¥2.9B | ¥2.9B |
| Property, plant and equipment | ¥6.6B | ¥9.12B | ¥9.11B | ¥8.38B | ¥9.03B |
| Intangible assets excluding goodwill | ¥86M | ¥117M | ¥135M | ¥107M | ¥110M |
| Investment securities | ¥2.87B | ¥3.01B | ¥2.65B | ¥2.1B | ¥3.88B |
| Current assets | ¥11.8B | ¥12.3B | ¥13B | ¥13.5B | ¥15.6B |
| Current liabilities | ¥4.91B | ¥6.48B | ¥5.95B | ¥6.3B | ¥8.3B |
| Trade payables | ¥1.49B | ¥1.46B | ¥1.16B | ¥1.68B | ¥2.32B |
| Short-term borrowings | ¥900M | ¥700M | ¥1.43B | ¥1.52B | ¥1.5B |
| Long-term borrowings | ¥1.93B | ¥1.83B | ¥2.69B | ¥2.13B | ¥3.36B |
| Bonds | ¥268M | ¥909M | ¥627M | ¥400M | ¥200M |
| Interest-bearing debt | ¥3.1Bderived | ¥3.44Bderived | ¥4.74Bderived | ¥4.05Bderived | ¥5.06Bderived |
| Total liabilities | ¥7.25B | ¥9.52B | ¥10.4B | ¥9.47B | ¥12.4B |
| Equity attributable to owners of parent | ¥13.3B | ¥14.1B | ¥13B | ¥13.7B | ¥14.3B |
| Retained earnings | ¥6.23B | ¥7.01B | ¥5.89B | ¥6.6B | ¥7.27B |
| Treasury stock | -¥249M | -¥249M | -¥249M | -¥249M | -¥249M |
EDINET (FSA Japan)
有価証券報告書－第80期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第79期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第78期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第77期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第76期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第75期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 52 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.